Lyrica
Product Images NDC 42549-660

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 42549-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panelndc: 42549-612-30lyrica 75mg #30 Tablets (Lyrica 50 mg C V 42549)

Principal Display Panelndc: 42549-612-30lyrica 75mg #30 Tablets (Lyrica 50 mg C V 42549)
FDA Label Image

Principal Display Panel (Lyrica 75 mg C V 42549)

Principal Display Panel (Lyrica 75 mg C V 42549)
This is a medication label for Duroea containing Pregabalin 75mg per capsule. It also lists the NDC number, lot number, and discard date. The label is from a pharmacy in Gainesville.*
FDA Label Image

Figure Of The Cockcroft And Gault Equation (Lyrica 1)

Figure Of The Cockcroft And Gault Equation (Lyrica 1)
This text appears to be a formula, possibly related to calculating the creatinine clearance rate for female patients. It involves using the person's age (in years) subtracted from 140, multiplying their weight (in kilograms) by 5, and then multiplying their serum creatinine (in mg/dL) by 72. There is also a notation about the clearance rate being 85% for female patients.*
FDA Label Image

Figure 8: Patients Achieving Various Levels Of Pain Relief – Fibromyalgia Study F1 (Lyrica 10)

Figure 8: Patients Achieving Various Levels Of Pain Relief – Fibromyalgia Study F1 (Lyrica 10)
FDA Label Image

Figure 9: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Lyrica 11)

Figure 9: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Lyrica 11)
FDA Label Image

The Chemical Structure Of Pregabalin. (Lyrica 2)

The Chemical Structure Of Pregabalin. (Lyrica 2)
FDA Label Image

Figure 1: Patients Achieving Various Levels Of Pain Relief – Study Dpn 1 (Lyrica 3)

Figure 1: Patients Achieving Various Levels Of Pain Relief – Study Dpn 1 (Lyrica 3)
FDA Label Image

Figure 2: Patients Achieving Various Levels Of Pain Relief – Study Dpn 2 (Lyrica 4)

Figure 2: Patients Achieving Various Levels Of Pain Relief – Study Dpn 2 (Lyrica 4)
FDA Label Image

Figure 3: Patients Achieving Various Levels Of Pain Relief – Study Phn 1 (Lyrica 5)

Figure 3: Patients Achieving Various Levels Of Pain Relief – Study Phn 1 (Lyrica 5)
FDA Label Image

Figure 4: Patients Achieving Various Levels Of Pain Relief – Study Phn 2 (Lyrica 6)

Figure 4: Patients Achieving Various Levels Of Pain Relief – Study Phn 2 (Lyrica 6)
FDA Label Image

Figure 5: Patients Achieving Various Levels Of Pain Relief – Study Phn 3 (Lyrica 7)

Figure 5: Patients Achieving Various Levels Of Pain Relief – Study Phn 3 (Lyrica 7)
This text is not available.*
FDA Label Image

Figure 6. Responder Rate By Add-on Epilepsy Study (Lyrica 8)

Figure 6. Responder Rate By Add-on Epilepsy Study (Lyrica 8)
FDA Label Image

Figure 7. Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Lyrica 9)

Figure 7. Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Lyrica 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.